We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 27 juli 2017

Latest content from npj Vaccines: 27 July 2017

If you are unable to see the message below, click here to view.
npj Vaccines

Advertisement
npj Vaccines is an online-only, open access, multidisciplinary journal dedicated to publishing cutting-edge research and development on human and veterinary vaccines. npj Vaccines is now open for submissions.

Explore the benefits of submitting your next manuscript to the journal.

Table of Contents: July 2017

Article | 17 July 2017

Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells

Nandadeva Lokugamage & Tetsuro Ikegami

npj Vaccines 2, Article number: 20 | doi:10.1038/s41541-017-0021-9

Review Article | 10 July 2017

Antibody therapies for the prevention and treatment of viral infections

Georgina Salazar, Ningyan Zhang, Tong-Ming Fu & Zhiqiang An

npj Vaccines 2, Article number: 19 | doi:10.1038/s41541-017-0019-3

Article | 06 July 2017

DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections

Sarah T. C. Elliott, Nicole L. Kallewaard, Ebony Benjamin, Leslie Wachter-Rosati, Josephine M. McAuliffe et al.

npj Vaccines 2, Article number: 18 | doi:10.1038/s41541-017-0020-x

Your email address is in the npj Vaccines mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature